In accordance with general kynurenine pathway changes mentioned before, IDO-Kyn-AhR pathway is activated by IFN-β or IFN-γ in alveolar epithelial cells, leading to an accumulation of mucins, thus triggering hypoxia of COVID-19 [28]. The gene discussed is IDO1; the disease is COVID-19.